Diagnostics Science Articles | Technology Networks

Young girl with headphones wearing a yellow hoodie, representing autism and sensory sensitivity.

Article

Largest Review Finds No Strong Evidence for Alternative Autism Treatments

A Q&A with Dr. Corentin J. Gosling, lead author of an umbrella review, explores the evidence behind complementary and alternative autism therapies. Covering 200 trials and 10,000 participants, the review found no strong proof of benefit.

Digital brain illustration with glowing neural connections symbolizing AI research in Alzheimer's.

Article

$1M Prize Will Advance AI-Powered Alzheimer’s Discoveries

We spoke with Dr. Niranjan Bose, managing director (Health & Life Sciences Strategy) at Gates Ventures, about a new $1M prize to advance dementia research using artificial intelligence.

Article

Bringing Mass Spectrometry to the Point-of-Care in Cancer Research

For many cancers, surgical resection is the primary treatment option. However, traditional tissue analysis is slow and error-prone; point-of-care MS tools like the MasSpec Pen could improve cancer detection.

Doctor holding digital DNA strand hologram, representing direct-to-consumer genetic testing.

Article

The Familial Ethics of Direct-to-Consumer Genetic Testing

Dr. Jennifer Mann, associate director of Science at UK Biocentre, explains why a blind spot in current direct-to-consumer genetic testing practices requires closer analysis and change.

3D-rendered brain shaped like Earth with neural network overlay, symbolizing global Alzheimer’s research.

Article

Dementia Research Is “On the Cusp of a Major Breakthrough”

We spoke with Dr. Niranjan Bose, managing director, Health & Life Sciences Strategy, Gates Ventures, about how proteomics-based biomarkers and international partnerships are changing the future of neurodegenerative disease research.

Article

Decoding the Aging Process With Mass Spectrometry

This article explores how mass spectrometry and emerging analytical techniques are helping researchers decode the aging proteome at multiple scales – from plasma to specific tissues to individual organelles.

Digital illustration of a brain with fragments symbolizing the focus on Alzheimer's biomarkers, with white text reading "Biomarkers in Focus" overlayed.

Article

What Blood Biomarkers Can – and Can’t – Tell Us About Alzheimer’s

Researchers are investigating blood-based biomarkers like pTau217 for Alzheimer’s detection, offering a less invasive alternative to traditional methods. However, challenges remain due to the interference of proteins from other organs.

Artistic rendering of a circulating tumor cell with "arms" stretching out into the surrounding space.

Article

Circulating microRNAs Track Circulating Tumor Cells in Metastatic Colorectal Cancer

Learn how specific miRNA signatures have potential as metastatic colorectal cancer biomarkers, enhancing non-invasive detection and patient risk stratification.

Article

EEG Biomarkers: The Future of Monitoring Neurological Health?

Learn about the potential of EEG biomarkers in the early detection and monitoring of neurological diseases such as Alzheimer's with Dr. Javier Escudero, reader in biomedical signal processing at the University of Edinburgh.